| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |